KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EBT (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of EBT data on record, last reported at $98.0 million in Q4 2025.

  • For Q4 2025, EBT rose 119.77% year-over-year to $98.0 million; the TTM value through Dec 2025 reached $830.8 million, up 229.94%, while the annual FY2025 figure was $830.8 million, 229.94% up from the prior year.
  • EBT reached $98.0 million in Q4 2025 per ZBH's latest filing, down from $279.2 million in the prior quarter.
  • Across five years, EBT topped out at $302.2 million in Q2 2024 and bottomed at -$725.8 million in Q4 2023.
  • Average EBT over 5 years is $84.6 million, with a median of $206.8 million recorded in 2021.
  • The widest YoY moves for EBT: up 183.4% in 2023, down 533.05% in 2023.
  • A 5-year view of EBT shows it stood at -$675.9 million in 2021, then skyrocketed by 124.8% to $167.6 million in 2022, then tumbled by 533.05% to -$725.8 million in 2023, then soared by 31.69% to -$495.8 million in 2024, then surged by 119.77% to $98.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $98.0 million in Q4 2025, $279.2 million in Q3 2025, and $224.6 million in Q2 2025.